{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:39:52Z","timestamp":1775853592489,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Center of Portuguese Oncology Institute of Porto","award":["FB-GEBC-27 and 19-CI-IPOP-2016"],"award-info":[{"award-number":["FB-GEBC-27 and 19-CI-IPOP-2016"]}]},{"name":"FCT- Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia PhD fellowship","award":["SFRH\/BD\/92786\/2013"],"award-info":[{"award-number":["SFRH\/BD\/92786\/2013"]}]},{"name":"IPO Porto","award":["IPO\/ESTIMA-1 NORTE-01-0145-FEDER-000027"],"award-info":[{"award-number":["IPO\/ESTIMA-1 NORTE-01-0145-FEDER-000027"]}]},{"name":"FCT","award":["PCT: PEst- UID\/DTP\/00776\/2013 and COMPETE: POCI-01-0145-FEDER-006868"],"award-info":[{"award-number":["PCT: PEst- UID\/DTP\/00776\/2013 and COMPETE: POCI-01-0145-FEDER-006868"]}]},{"name":"FCT-Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["IF\/00601\/2012"],"award-info":[{"award-number":["IF\/00601\/2012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13148-018-0475-2","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:47:50Z","timestamp":1522802870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97"],"prefix":"10.1186","volume":"10","author":[{"given":"Jo\u00e3o","family":"Ramalho-Carvalho","sequence":"first","affiliation":[]},{"given":"C\u00e9line S.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Gra\u00e7a","sequence":"additional","affiliation":[]},{"given":"David","family":"Bidarra","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Pereira-Silva","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Salta","sequence":"additional","affiliation":[]},{"given":"Maria In\u00eas","family":"Godinho","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Gomez","sequence":"additional","affiliation":[]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[]},{"given":"Bruno M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10555-016-9628-y","volume":"35","author":"J Ramalho-Carvalho","year":"2016","unstructured":"Ramalho-Carvalho J, Fromm B, Henrique R, Jeronimo C. Deciphering the function of non-coding RNAs in prostate cancer. Cancer Metastasis Rev. 2016;35:235\u201362.","journal-title":"Cancer Metastasis Rev"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-genet-120213-092023","volume":"49","author":"B Fromm","year":"2015","unstructured":"Fromm B, Billipp T, Peck LE, Johansen M, Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E, Peterson KJ. A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome. Annu Rev Genet. 2015;49:213\u201342.","journal-title":"Annu Rev Genet"},{"key":"475_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16:421\u201333.","journal-title":"Nat Rev Genet"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","volume":"115","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787\u201398.","journal-title":"Cell"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tcb.2014.11.004","volume":"25","author":"JA Vidigal","year":"2015","unstructured":"Vidigal JA, Ventura A. The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol. 2015;25:137\u201347.","journal-title":"Trends Cell Biol"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"R762","DOI":"10.1016\/j.cub.2014.06.043","volume":"24","author":"BD Adams","year":"2014","unstructured":"Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24:R762\u201376.","journal-title":"Curr Biol"},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347\u201355.","journal-title":"Nature"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"Cancer Genome Atlas Research N","year":"2015","unstructured":"Cancer Genome Atlas Research N. The molecular taxonomy of primary prostate Cancer. Cell. 2015;163:1011\u201325.","journal-title":"Cell"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","volume":"70","author":"L Fabris","year":"2016","unstructured":"Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA. The potential of MicroRNAs as prostate Cancer biomarkers. Eur Urol. 2016;70:312\u201322.","journal-title":"Eur Urol"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nbt.3450","volume":"34","author":"G Korkmaz","year":"2016","unstructured":"Korkmaz G, Lopes R, Ugalde AP, Nevedomskaya E, Han R, Myacheva K, Zwart W, Elkon R, Agami R. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nat Biotechnol. 2016;34:192\u20138.","journal-title":"Nat Biotechnol"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42:e168.","journal-title":"Nucleic Acids Res"},{"key":"475_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13148-015-0076-2","volume":"7","author":"P Costa-Pinheiro","year":"2015","unstructured":"Costa-Pinheiro P, Ramalho-Carvalho J, Vieira FQ, Torres-Ferreira J, Oliveira J, Goncalves CS, Costa BM, Henrique R, Jeronimo C. MicroRNA-375 plays a dual role in prostate carcinogenesis. Clin Epigenetics. 2015;7:42.","journal-title":"Clin Epigenetics"},{"key":"475_CR15","first-page":"1799","volume":"6","author":"AS Pires-Luis","year":"2016","unstructured":"Pires-Luis AS, Vieira-Coimbra M, Ferreira MJ, Ramalho-Carvalho J, Costa-Pinheiro P, Antunes L, Dias PC, Lobo F, Oliveira J, Graca I, et al. Prognostic significance of MST1R dysregulation in renal cell tumors. Am J Cancer Res. 2016;6:1799\u2013811.","journal-title":"Am J Cancer Res"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139.","journal-title":"Bioinformatics"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"475_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1530\/ERC-13-0375","volume":"21","author":"FQ Vieira","year":"2014","unstructured":"Vieira FQ, Costa-Pinheiro P, Ramalho-Carvalho J, Pereira A, Menezes FD, Antunes L, Carneiro I, Oliveira J, Henrique R, Jeronimo C. Deregulated expression of selected histone methylases and demethylases in prostate carcinoma. Endocr Relat Cancer. 2014;21:51\u201361.","journal-title":"Endocr Relat Cancer"},{"key":"475_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1593\/neo.12600","volume":"14","author":"P Paulo","year":"2012","unstructured":"Paulo P, Ribeiro FR, Santos J, Mesquita D, Almeida M, Barros-Silva JD, Itkonen H, Henrique R, Jeronimo C, Sveen A, et al. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements. Neoplasia. 2012;14:600\u201311.","journal-title":"Neoplasia"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2016.10.028","volume":"385","author":"J Ramalho-Carvalho","year":"2017","unstructured":"Ramalho-Carvalho J, Martins JB, Cekaite L, Sveen A, Torres-Ferreira J, Graca I, Costa-Pinheiro P, Eilertsen IA, Antunes L, Oliveira J, et al. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Lett. 2017;385:150\u20139.","journal-title":"Cancer Lett"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13045-017-0415-1","volume":"10","author":"J Ramalho-Carvalho","year":"2017","unstructured":"Ramalho-Carvalho J, Graca I, Gomez A, Oliveira J, Henrique R, Esteller M, Jeronimo C. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. J Hematol Oncol. 2017;10:43.","journal-title":"J Hematol Oncol"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.4161\/epi.6.6.16196","volume":"6","author":"J Sandoval","year":"2011","unstructured":"Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011;6:692\u2013702.","journal-title":"Epigenetics"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"GR Abecasis","year":"2010","unstructured":"Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061\u201373.","journal-title":"Nature"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-017-0604-0","volume":"16","author":"J Torres-Ferreira","year":"2017","unstructured":"Torres-Ferreira J, Ramalho-Carvalho J, Gomez A, Menezes FD, Freitas R, Oliveira J, Antunes L, Bento MJ, Esteller M, Henrique R, Jeronimo C. MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b\/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors. Mol Cancer. 2017;16:26.","journal-title":"Mol Cancer"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.18632\/oncotarget.1953","volume":"5","author":"SC Theodore","year":"2014","unstructured":"Theodore SC, Davis M, Zhao F, Wang H, Chen D, Rhim J, Dean-Colomb W, Turner T, Ji W, Zeng G, et al. MicroRNA profiling of novel African American and Caucasian prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1. Oncotarget. 2014;5:3512\u201325.","journal-title":"Oncotarget"},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1093\/hmg\/ddx138","volume":"26","author":"K Daniunaite","year":"2017","unstructured":"Daniunaite K, Dubikaityte M, Gibas P, Bakavicius A, Rimantas Lazutka J, Ulys A, Jankevicius F, Jarmalaite S. Clinical significance of miRNA host gene promoter methylation in prostate cancer. Hum Mol Genet. 2017;26:2451\u201361.","journal-title":"Hum Mol Genet"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2016.05.053","volume":"165","author":"MW Popp","year":"2016","unstructured":"Popp MW, Maquat LE. Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine. Cell. 2016;165:1319\u201322.","journal-title":"Cell"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"MS Ebert","year":"2012","unstructured":"Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149:515\u201324.","journal-title":"Cell"},{"key":"475_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm.1880","volume":"14","author":"D Bonci","year":"2008","unstructured":"Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14:1271\u20137.","journal-title":"Nat Med"},{"key":"475_CR30","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1038\/ncomms11452","volume":"7","author":"X Jiang","year":"2016","unstructured":"Jiang X, Hu C, Arnovitz S, Bugno J, Yu M, Zuo Z, Chen P, Huang H, Ulrich B, Gurbuxani S, et al. miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun. 2016;7:11452.","journal-title":"Nat Commun"},{"key":"475_CR31","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1038\/onc.2014.222","volume":"34","author":"A Kroiss","year":"2015","unstructured":"Kroiss A, Vincent S, Decaussin-Petrucci M, Meugnier E, Viallet J, Ruffion A, Chalmel F, Samarut J, Allioli N. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene. 2015;34:2846\u201355.","journal-title":"Oncogene"},{"key":"475_CR32","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.18632\/oncotarget.2294","volume":"5","author":"Y Goto","year":"2014","unstructured":"Goto Y, Kojima S, Nishikawa R, Enokida H, Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T, Seki N. The microRNA-23b\/27b\/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Oncotarget. 2014;5:7748\u201359.","journal-title":"Oncotarget"},{"key":"475_CR33","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1038\/onc.2016.6","volume":"35","author":"MA Rice","year":"2016","unstructured":"Rice MA, Ishteiwy RA, Magani F, Udayakumar T, Reiner T, Yates TJ, Miller P, Perez-Stable C, Rai P, Verdun R, et al. The microRNA-23b\/-27b cluster suppresses prostate cancer metastasis via huntingtin-interacting protein 1-related. Oncogene. 2016;35:4752\u201361.","journal-title":"Oncogene"},{"key":"475_CR34","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1158\/0008-5472.CAN-12-2181","volume":"72","author":"S Majid","year":"2012","unstructured":"Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, Dahiya R. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res. 2012;72:6435\u201346.","journal-title":"Cancer Res"},{"key":"475_CR35","doi-asserted-by":"publisher","first-page":"e1005826","DOI":"10.1371\/journal.pgen.1005826","volume":"12","author":"H Heyn","year":"2016","unstructured":"Heyn H. Quantitative trait loci identify functional noncoding variation in Cancer. PLoS Genet. 2016;12:e1005826.","journal-title":"PLoS Genet"},{"key":"475_CR36","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nrg3079","volume":"12","author":"E Berezikov","year":"2011","unstructured":"Berezikov E. Evolution of microRNA diversity and regulation in animals. Nat Rev Genet. 2011;12:846\u201360.","journal-title":"Nat Rev Genet"},{"key":"475_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.emboj.7601512","volume":"26","author":"YK Kim","year":"2007","unstructured":"Kim YK, Kim VN. Processing of intronic microRNAs. EMBO J. 2007;26:775\u201383.","journal-title":"EMBO J"},{"key":"475_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1758-907X-1-5","volume":"1","author":"M Isik","year":"2010","unstructured":"Isik M, Korswagen HC, Berezikov E. Expression patterns of intronic microRNAs in Caenorhabditis elegans. Silence. 2010;1:5.","journal-title":"Silence"},{"key":"475_CR39","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1101\/gr.083055.108","volume":"18","author":"NJ Martinez","year":"2008","unstructured":"Martinez NJ, Ow MC, Reece-Hoyes JS, Barrasa MI, Ambros VR, Walhout AJ. Genome-scale spatiotemporal analysis of Caenorhabditis elegans microRNA promoter activity. Genome Res. 2008;18:2005\u201315.","journal-title":"Genome Res"},{"key":"475_CR40","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-11-0364","volume":"71","author":"T Tsuruta","year":"2011","unstructured":"Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 2011;71:6450\u201362.","journal-title":"Cancer Res"},{"key":"475_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/leu.2010.282","volume":"25","author":"DJ Stumpel","year":"2011","unstructured":"Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, de Menezes RX, Marquez VE, Pieters R, den Boer ML, Stam RW. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia. 2011;25:429\u201339.","journal-title":"Leukemia"},{"key":"475_CR42","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.febslet.2014.04.022","volume":"588","author":"Y Su","year":"2014","unstructured":"Su Y, Wang Y, Zhou H, Lei L, Xu L. MicroRNA-152 targets ADAM17 to suppress NSCLC progression. FEBS Lett. 2014;588:1983\u20138.","journal-title":"FEBS Lett"},{"key":"475_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/onc.2012.575","volume":"33","author":"Y Xiang","year":"2014","unstructured":"Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y, et al. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene. 2014;33:378\u201386.","journal-title":"Oncogene"},{"key":"475_CR44","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1373\/clinchem.2013.205450","volume":"59","author":"Z Lichner","year":"2013","unstructured":"Lichner Z, Fendler A, Saleh C, Nasser AN, Boles D, Al-Haddad S, Kupchak P, Dharsee M, Nuin PS, Evans KR, et al. MicroRNA signature helps distinguish early from late biochemical failure in prostate cancer. Clin Chem. 2013;59:1595\u2013603.","journal-title":"Clin Chem"},{"key":"475_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.7150\/jca.12351","volume":"7","author":"H Chen","year":"2016","unstructured":"Chen H, Liu H, Zou H, Chen R, Dou Y, Sheng S, Dai S, Ai J, Melson J, Kittles RA, et al. Evaluation of plasma miR-21 and miR-152 as diagnostic biomarkers for common types of human cancers. J Cancer. 2016;7:490\u20139.","journal-title":"J Cancer"},{"key":"475_CR46","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/pros.22656","volume":"73","author":"C Zhu","year":"2013","unstructured":"Zhu C, Li J, Ding Q, Cheng G, Zhou H, Tao L, Cai H, Li P, Cao Q, Ju X, et al. miR-152 controls migration and invasive potential by targeting TGFalpha in prostate cancer cell lines. Prostate. 2013;73:1082\u20139.","journal-title":"Prostate"},{"key":"475_CR47","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.1007\/s13277-015-3552-6","volume":"36","author":"G Qiu","year":"2015","unstructured":"Qiu G, Sun W, Zou Y, Cai Z, Wang P, Lin X, Huang J, Jiang L, Ding X, Hu G. RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells. Tumour Biol. 2015;36:8231\u20138.","journal-title":"Tumour Biol"},{"key":"475_CR48","first-page":"91","volume":"30","author":"SB Moparthi","year":"2007","unstructured":"Moparthi SB, Arbman G, Wallin A, Kayed H, Kleeff J, Zentgraf H, Sun XF. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int J Oncol. 2007;30:91\u20135.","journal-title":"Int J Oncol"},{"key":"475_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12032-012-0324-7","volume":"30","author":"S Yang","year":"2013","unstructured":"Yang S, Li H, Liu Y, Ning X, Meng F, Xiao M, Wang D, Lou G, Zhang Y. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Med Oncol. 2013;30:324.","journal-title":"Med Oncol"},{"key":"475_CR50","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s13277-012-0612-z","volume":"34","author":"KY Han","year":"2013","unstructured":"Han KY, Gu X, Wang HR, Liu D, Lv FZ, Li JN. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer. Tumour Biol. 2013;34:821\u20135.","journal-title":"Tumour Biol"},{"key":"475_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-5793(98)00477-3","volume":"428","author":"MP Svetlova","year":"1998","unstructured":"Svetlova MP, Solovjeva LV, Nikiforov AA, Chagin VA, Lehmann AR, Tomilin NV. Staurosporine-sensitive protein phosphorylation is required for postreplication DNA repair in human cells. FEBS Lett. 1998;428:23\u20136.","journal-title":"FEBS Lett"},{"key":"475_CR52","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1186\/1471-2164-11-S1-S9","volume":"11 Suppl 1","author":"OV Grinchuk","year":"2010","unstructured":"Grinchuk OV, Motakis E, Kuznetsov VA. Complex sense-antisense architecture of TNFAIP1\/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression. BMC Genomics. 2010;11 Suppl 1:S9.","journal-title":"BMC Genomics"},{"key":"475_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jmcb\/mjs049","volume":"5","author":"Q Xu","year":"2013","unstructured":"Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, et al. A regulatory circuit of miR-148a\/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol. 2013;5:3\u201313.","journal-title":"J Mol Cell Biol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0475-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-018-0475-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0475-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:08:07Z","timestamp":1553630887000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-018-0475-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s13148-018-0475-2","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional ethics committee [Comiss\u00e3o de \u00c9tica para a Sa\u00fade- Instituto Portugu\u00eas de Oncologia do Porto Francisco Gentil, EPE (CES-IPOPFG-EPE 215\/013)]. Moreover, in compliance with the Helsinki Declaration and after CES approval, informed consent was obtained for all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"40"}}